The slice of patients above the age of 60
consumes about 85 % of the drugs and devices and diagnostics out there,» says Justin Stephenson, senior life sciences analyst at Vancouver - based independent investment dealer Haywood Securities Inc. «That is only going to get significantly bigger in the western world, which is the main market for Canadian
health -
care products in the next five to 10 years.